Zoekresultaten - 6 results
Surveillance of antimicrobial resistant bacteria in Belgian hospitals: Report 2016
Enterobacteriaceae, especially in Klebsiella pneumoniae (K. pneumoniae) in acute care hospitals. The mean resistance proportion of extended beta-lactamase producing (ESBL +) K. pneumoniae increased from 6.2% in 2005 to ...
European Antimicrobial Resistance Surveillance Network (EARS-Net Belgium)- Report 2017 (Data up to and including 2016)
fluoroquinolones, leading to countrywide resistance percentages in 2016 of 10.5% and 24.5%, respectively. An increasing trend could also be observed for antimicrobial resistance of Klebsiella pneumoniae to ...
OXA-48 Producing Klebsiella pneumoniae in a Household Contact of a Previously Infected Patient: Person-to-Person Transmission or Coincidental Community Acquisition?
Resistance, Multiple, Bacterial Electrophoresis, Gel, Pulsed-Field Family Characteristics Female Gene Expression Humans Klebsiella Infections Klebsiella pneumoniae Microbial Sensitivity Tests Multilocus ...
Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health.
being used as a last-resort drug to treat infections caused by multidrug-resistant (MDR) Pseudomonas aeruginosa, Acinetobacter baumannii and Enterobacteriaceae (e.g., Escherichia coli, Klebsiella ...
Surveillance of bloodstream infections in Belgian hospitals ('SEP')-Annual report 2014, Surveillance data 2000-2014
microorganisms involved in HA- BSI changed with an increase in the incidence of HA- BSI due to Gram-negative microorganisms (Escherichia coli, Klebsiella pneumoniae) and a decrease of HA- BSI due to ...
Surveillance septicemieën in Belgische ziekenhuizen- Jaarrapport 2013, gegevens 2000-2013
2000 to 2.0/10,000 pd in 2013. For Klebsiella pneumoniae it rose from 0.3 to 0.6/10,000 pd, respectively. The annual mean incidence density of BSI associated with a central line (CLABSI) was 2.2/10,000 ...